title: Acute cardiac ongoing rejection: comparison between different strategies.
authors.affiliation: Division of Cardiac Surgery, OCM, Verona, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Forni
authors.forename: G
authors.initials: G
authors.lastname: Faggian
authors.forename: G B
authors.initials: GB
authors.lastname: Luciani
authors.forename: N
authors.initials: N
authors.lastname: Lamascese
authors.forename: A
authors.initials: A
authors.lastname: Mazzucco
authors.forename: N
authors.initials: N
authors.lastname: Lamasciese
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy*; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D012189:Retrospective Studies
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone